Hi iandy,
I thought they already did a large free distribution of sample packs earlier in the First quarter. In the Second Q Report they point out the following,
As of June 30, 2017, over 61% of adult CIC patients with commercial insurance will have unrestricted access to TRULANCE for 2017 based on the top 20 pharmacy benefit managers (PBMs) and payers. Additionally, approximately 95% of people with commercial insurance had access to TRULANCE for a co-pay of $25 or less through the TRULANCE Savings-to-Go-Program.
They have secured a 2018 managed care contract with CVS Caremark, which manages approximately 50 million commercial lives in the U.S., that will place TRULANCE on formulary without restriction (non-preferred) for its Commercial Template Clients or Employer Groups, representing approximately 24 million lives. We are in contract discussions with CVS Caremark for the remaining commercial lives.
TRULANCE and possible changes through Express Scripts (ESI) and the commercial formulary status in the future.
They are also in active contract negotiations with other PBMs and payers for 2018 coverage to ensure our goal of broad access to TRULANCE.
Med D and Medicaid discussions are ongoing and we expect several major accounts to include TRULANCE on formulary in 2018.
Finally, if the sNDA is approved in IBS-C in Jan 2018, that might add some additional prescriptions to strengthen the growth.
Hope for the best. Sooner the better.
